166 related articles for article (PubMed ID: 23472968)
1. HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia.
Roy S; Di Cello F; Kowalski J; Hristov AC; Tsai HL; Bhojwani D; Meyer JA; Carroll WL; Belton A; Resar LM
Leuk Lymphoma; 2013 Nov; 54(11):2565-7. PubMed ID: 23472968
[No Abstract] [Full Text] [Related]
2. An unrelated cytogenetic karyotype and intra-lineage shift at relapse of an aggressive paediatric B-precursor ALL.
Weston VJ; Stankovic T; McMullan DJ; Drayson M; Ley BE; Lawson S; Hill FG
Leukemia; 2002 Nov; 16(11):2337-9. PubMed ID: 12399984
[No Abstract] [Full Text] [Related]
3. Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.
Mikami T; Kato I; Wing JB; Ueno H; Tasaka K; Tanaka K; Kubota H; Saida S; Umeda K; Hiramatsu H; Isobe T; Hiwatari M; Okada A; Chiba K; Shiraishi Y; Tanaka H; Miyano S; Arakawa Y; Oshima K; Koh K; Adachi S; Iwaisako K; Ogawa S; Sakaguchi S; Takita J
Cancer Sci; 2022 Jan; 113(1):41-52. PubMed ID: 34716967
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous carriers of germline c.657_661del5 founder mutation in
Tomasik B; Pastorczak A; Fendler W; Bartłomiejczyk M; Braun M; Mycko M; Madzio J; Polakowska E; Ulińska E; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Badowska W; Kazanowska B; Szczepański T; Styczyński J; Irga-Jaworska N; Młynarski W;
Haematologica; 2018 May; 103(5):e200-e203. PubMed ID: 29419426
[No Abstract] [Full Text] [Related]
5. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract][Full Text] [Related]
6. Low expression of
Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
[TBL] [Abstract][Full Text] [Related]
7. CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment.
Mejstríková E; Hrusak O; Borowitz MJ; Whitlock JA; Brethon B; Trippett TM; Zugmaier G; Gore L; von Stackelberg A; Locatelli F
Blood Cancer J; 2017 Dec; 7(12):659. PubMed ID: 29259173
[No Abstract] [Full Text] [Related]
8. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
10.
Passet M; Boissel N; Sigaux F; Saillard C; Bargetzi M; Ba I; Thomas X; Graux C; Chalandon Y; Leguay T; Lengliné E; Konopacki J; Quentin S; Delabesse E; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Lhéritier V; Soulier J; Dombret H; Clappier E;
Blood; 2019 Jan; 133(3):280-284. PubMed ID: 30510083
[No Abstract] [Full Text] [Related]
11. Clonal diversity of Ig and T-cell-receptor gene rearrangements identifies a subset of childhood B-precursor acute lymphoblastic leukemia with increased risk of relapse.
Green E; McConville CM; Powell JE; Mann JR; Darbyshire PJ; Taylor AM; Stankovic T
Blood; 1998 Aug; 92(3):952-8. PubMed ID: 9680364
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
[TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Lauten M; Asgedom G; Welte K; Schrappe M; Stanulla M
Haematologica; 2003 Mar; 88(3):353-4. PubMed ID: 12651279
[No Abstract] [Full Text] [Related]
15. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targets in childhood B-acute lymphoblastic leukemia: what about HER2/neu?
Camuset M; Huault A; Grain A; Clémenceau B; Rialland F; Thomas C; Chevallier P; Béné MC; Eveillard M
Hematol Oncol; 2021 Apr; 39(2):270-272. PubMed ID: 32894593
[No Abstract] [Full Text] [Related]
17. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
Kuiper RP; Waanders E; van der Velden VH; van Reijmersdal SV; Venkatachalam R; Scheijen B; Sonneveld E; van Dongen JJ; Veerman AJ; van Leeuwen FN; van Kessel AG; Hoogerbrugge PM
Leukemia; 2010 Jul; 24(7):1258-64. PubMed ID: 20445578
[TBL] [Abstract][Full Text] [Related]
18. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract][Full Text] [Related]
19. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
20. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
Umiel T; Pattengale P; Weinberg K
Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
